Skip to main content

Palvella Therapeutics, Inc.

PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583648

In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 198 institutions reported holding it in 13F filings for Q3 2026, worth $2.01B in total; no superinvestor holds it.

Holders of 5% or more of PVLA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Palvella Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PVLA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Kaupinen Wes13D14.60%1.64M sharesNewDec 20, 20241 filingDec 20, 2024SEC
Jennison Associates LLC13G/A7.70%1.10M shares+1.00 ppfrom 6.70%Aug 3, 20262 filingsOct 28, 2026SEC
Suvretta Capital Management, LLC13G/A7.40%822.4K shares−1.20 ppfrom 8.60%Dec 20, 20242 filingsNov 13, 2025SEC
Prudential Financial Inc13G6.70%962.4K sharesNewAug 10, 20261 filingAug 10, 2026SEC
Frazier Life Sciences Public Fund, L.P.13G/A5.90%848.4K shares−0.10 ppfrom 6.00%Jan 8, 20255 filingsNov 16, 2026SEC
BlackRock, Inc.13G5.70%813.0K sharesNewJul 29, 20261 filingJul 29, 2026SEC
First Light Asset Management, LLC13G/A5.34%769.1K shares−2.15 ppfrom 7.49%Feb 17, 20262 filingsAug 14, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

55 Schedule 13D and 13G filings on Palvella Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PVLA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20264:21 PM ETFrazier Life Sciences Public Fund, L.P.and 13 others13G/A5.90%848.4K shares−0.10 ppfrom 6.00%Sep 30, 2026SEC
Oct 28, 20263:44 PM ETJennison Associates LLC13G/A7.70%1.10M shares+1.00 ppfrom 6.70%Sep 30, 2026SEC
Aug 14, 20264:33 PM ETFirst Light Asset Management, LLCand 1 other13G/A5.34%769.1K shares−2.15 ppfrom 7.49%Jun 30, 2026SEC
Aug 14, 20264:18 PM ETBiotechnology Value Fund L Pand 9 others13G/A4.70%672.8K shares−2.40 ppfrom 7.10%Below 5%Jun 30, 2026SEC
Aug 10, 20262:12 PM ETPrudential Financial Inc13G6.70%962.4K sharesNewJun 30, 2026SEC
Aug 3, 202610:48 AM ETJennison Associates LLC13G6.70%960.6K sharesNewJun 30, 2026SEC
Jul 29, 20263:19 PM ETBlackRock, Inc.13G5.70%813.0K sharesNewJun 30, 2026SEC
Feb 17, 20264:34 PM ETFirst Light Asset Management, LLCand 1 other13G7.49%887.0K sharesNewDec 31, 2025SEC
Feb 17, 20264:21 PM ETBiotechnology Value Fund L Pand 9 others13G/A7.10%879.0K shares−2.89 ppfrom 9.99%Dec 31, 2025SEC
Feb 13, 20265:33 PM ETFrazier Life Sciences Public Fund, L.P.and 13 others13G/A6.00%706.4K shares+1.10 ppfrom 4.90%Dec 31, 2025SEC
Nov 14, 20254:19 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%1.18M shares–Sep 30, 2025SEC
Nov 13, 20255:31 PM ETSuvretta Capital Management, LLCand 2 others13G/A7.40%822.4K shares−1.20 ppfrom 8.60%Sep 30, 2025SEC
Aug 14, 20255:26 PM ETSamsara BioCapital, L.P.and 2 others13G/A3.10%339.7K shares−3.00 ppfrom 6.10%Below 5%Jun 30, 2025SEC
Aug 14, 20251:41 PM ETFrazier Life Sciences Public Fund, L.P.and 19 others13G/A4.90%545.5K shares−1.40 ppfrom 6.30%Below 5%Jun 30, 2025SEC
May 15, 20259:39 AM ETFrazier Life Sciences Public Fund, L.P.and 16 others13G/A6.30%690.0K shares+1.20 ppfrom 5.10%Mar 31, 2025SEC
Jan 8, 20253:04 PM ETFrazier Life Sciences Public Fund, L.P.and 16 others13G5.10%575.9K sharesNewDec 13, 2024SEC
Dec 20, 20245:32 PM ETKaupinen Wesand 4 others13D14.60%1.64M sharesNewDec 13, 2024SEC
Dec 20, 20244:59 PM ETSamsara BioCapital, L.P.and 2 others13G6.10%679.5K sharesNewDec 13, 2024SEC
Dec 20, 20244:56 PM ETSuvretta Capital Management, LLCand 2 others13G8.60%714.5K sharesNewDec 13, 2024SEC
Dec 17, 20244:22 PM ETDellora Investments LPand 2 others13G/A1.30%141.1K shares−9.40 ppfrom 10.70%Below 5%Dec 13, 2024SEC
Dec 17, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Dec 6, 20242:21 PM ETDellora Investments LPand 2 others13G/A10.70%141.1K shares+2.40 ppfrom 8.30%Nov 6, 2024SEC
Nov 14, 2024Lynx1 Capital Management LP13G/AOld format–––SEC
Aug 7, 20242:16 PM ETDellora Investments LPand 2 others13G8.30%109.0K sharesNewJul 24, 2024SEC
Aug 1, 2024ADAR1 Capital Management, LLC13GOld format–New–SEC
May 17, 2024Biotechnology Value Fund L P13GOld format–––SEC
May 17, 2024Biotechnology Value Fund L P13GOld format–––SEC
Feb 14, 2024Checkpoint Capital L.P.13G/AOld format–––SEC
Feb 14, 2024Aquilo Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2024Lynx1 Capital Management LP13G/AOld format–––SEC
Feb 2, 2024Soleus Capital Master Fund, L.P.13G/AOld format–––SEC
Aug 17, 2023Biotechnology Value Fund L P13D/AOld format–––SEC
Jun 12, 2023Checkpoint Capital L.P.13GOld format–New–SEC
May 22, 2023Biotechnology Value Fund L P13DOld format–––SEC
Feb 14, 2023Aquilo Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2023Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2023Lynx1 Capital Management LP13G/AOld format–––SEC
Feb 10, 20234:20 PM ETSeagen Inc.13G/AOld format–––SEC
Feb 10, 202310:22 AM ETAstraZeneca PLC13G/AOld format–––SEC
Jan 27, 2023Soleus Capital Master Fund, L.P.13GOld format–––SEC
Jan 26, 2023Soleus Capital Master Fund, L.P.13G/AOld format–––SEC
Oct 24, 2022Lynx1 Capital Management LP13GOld format–New–SEC
Feb 14, 2022Aquilo Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2022Nussbaum Ran13G/AOld format–––SEC
Feb 14, 2022Citadel Advisors LLC13G/AOld format–––SEC
Feb 14, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Jan 27, 2022Soleus Capital Master Fund, L.P.13GOld format–New–SEC
Jul 12, 20218:29 AM ETBlackRock Inc.13G/AOld format–––SEC
Jul 6, 2021Citadel Advisors LLC13GOld format–New–SEC
Apr 7, 20215:37 PM ETAstraZeneca PLC13GOld format–New–SEC

Form 144: proposed insider sales

16 notices from officers, directors and other affiliates planning to sell Palvella Therapeutics, Inc. shares, newest first.

Form 144 notices for PVLA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 10, 20264:28 PM ETJeffrey MartiniOfficer50.0K$8.70MNov 10, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Oct 21, 20264:21 PM ETGoin KathleenOfficer4.31K$534.5KOct 21, 202610b5-1Piper Sandler & Co IncSEC
Oct 13, 20264:59 PM ETJenkins George MDirector27.5K$3.70MOct 13, 202610b5-1Piper Sandler & CoSEC
Sep 16, 20264:31 PM ETGoin KathleenOfficer4.30K$650.5KSep 16, 202610b5-1Piper Sandler & Co IncSEC
Sep 11, 20264:34 PM ETJenkins George MDirector27.5K$4.14MSep 11, 202610b5-1Piper SandlerSEC
Sep 2, 20264:10 PM ETChristopher KiritsyDirector375$58.9KSep 2, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 19, 20264:56 PM ETGoin KathleenOfficer4.30K$647.1KAug 19, 202610b5-1Piper Sandler & Co IncSEC
Jul 15, 20264:20 PM ETGoin KathleenOfficer4.30K$643.9KJul 15, 202610b5-1Piper Sandler & Co IncSEC
Jun 17, 20265:11 PM ETGoin KathleenOfficer4.30K$476.4KJun 17, 202610b5-1Piper Sandler & Co IncSEC
May 20, 20265:47 PM ETGoin KathleenOfficer4.30K$475.6KMay 20, 202610b5-1Piper Sandler & Co IncSEC
Apr 15, 20264:00 PM ETGoin KathleenOfficer4.30K$557.2KApr 15, 202610b5-1Piper Sandler & Co IncSEC
Mar 18, 20264:01 PM ETGoin KathleenOfficer4.30K$519.7KMar 18, 202610b5-1Piper Sandler and CoSEC
Feb 19, 20265:51 PM ETAmendedGoin KathleenOfficer4.30K$344.5KFeb 18, 202610b5-1Piper Sandler & Co IncSEC
Jan 21, 20264:33 PM ETGoin KathleenOfficer4.30K$421.6KJan 21, 202610b5-1Piper Sandler & Co IncSEC
Dec 17, 20254:33 PM ETGoin KathleenOfficer4.30K$416.5KDec 17, 202510b5-1Piper Sandler & Co IncSEC
Nov 19, 20254:46 PM ETGoin KathleenOfficer4.30K$356.8KNov 19, 202510b5-1Piper Sandler & Co IncSEC